ADVERTISEMENT
Sunday, June 26th 2022
Today's Paper
The Kashmir Monitor
  • Login
₹ Contribute
No Result
View All Result
  • LatestLive
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Editorial
  • Business
  • Sports
  • Education
  • Health
  • Tech-Film
  • Auto
  • Crypto
  • Travel
Today's Paper
The Kashmir Monitor
  • Login
Contribute
No Result
View All Result
The Kashmir Monitor
Home Health

Covishield shows better antibody response than Covaxin, says study

Monitor News Desk by Monitor News Desk
Jun. 07, 2021 Updated 10:32 am. IST
A A
covi
0
SHARES
84
VIEWS
Share on FacebookShare on Twitter


 

Indian healthcare workers who were administered Covishield have shown better antibody response than the Covaxin recipients, revealed a recent study.

ADVERTISEMENT

The Cross-sectional Coronavirus Vaccine-induced Antibody Titre (COVAT) study were published in pre-print server MedRxiv on June 4.

The study was conducted on 515 vaccinated healthcare workers-415 with Covishield and 90 with Covaxin. The pan India study was conducted in 13 states and 22 cities and it found that the vaccines could generate an immune response in 95 per cent recipients 21-36 days after the second dose.

The seropositivity was observed in 98 per cent of those immunised with Covishield as opposed to 80 per cent Covaxin recipients. Anti-spike antibody titre was found to be significantly higher in Covishield recipients (115 AU/ml) compared to Covaxin (51 AU/ml), the study said.

The lead author of the study, Dr. Awadesh Kumar Singh of G D Hospitals and Diabetes Institute, Kolkata said that the study was not meant to comment on which vaccine was better, but to take a look at the real world effectiveness of the vaccination.

ADVERTISEMENT

“In the absence of measuring neutralising antibody and cell mediated response, it is difficult to comment whether one is superior,” Dr Kumar said.

He further added that in individuals who have had COVID-19, both vaccines are equally good and could produce high anti-bodies even after a single shot. Covishield however has the edge when it came to people who have not got COVID-19, he also added.


Next Post
J&K LG meets Amit Shah; Amarnath Yatra security review key agenda, says report

J&K LG meets Amit Shah; Amarnath Yatra security review key agenda, says report

Discussion about this post

Logo

Copyright © 1996 - 2022 - All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Monitor.

No Result
View All Result
  • Home Page
  • Latest News
  • Lead Stories
  • News
  • Kashmir
  • India
  • World
  • Politics
  • Education
  • Business
  • Environment
  • Health
  • Sports
  • Editors’ Picks
  • Videos
  • Lifestyle
  • Tech-Film
  • Today’s Paper

Copyright © 1996 - 2022 - All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Monitor.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In